Company profilePharmaceutical#572 of 1,318 in Pakistan✓ No DRAP alerts

A.J. & COMPANY.

Pharmaceutical company · 21 brands · 22 molecules

Ranked #5 of 36 companies in Cardiac Therapy

21 registered products 14 pharmaceutical brands 22 distinct molecules 0 DRAP alerts

Company overview

21
registered products
14
pharmaceutical brands
22
distinct molecules
11
therapeutic classes
0
DRAP alerts

A.J. & COMPANY. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 21 product registrations across 22 distinct molecules. Its portfolio is concentrated in Cardiac Therapy and Anaesthetic, General. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by A.J.

3 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Propofol1 brand
Atorvastqatin Usp......20Mg1 brand
Atorvastqatin Usp......10Mg1 brand
Ranitidine1 brand
Dobutamine1 brand
Omeprazole1 brand

Therapeutic classes

Cardiac Therapy · 3Anaesthetic, General · 1Lipid Modifying Agents · 1Other Beta-Lactam, Cephalosporins & Penems · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Beta Blocking Agent · 1Calcium Channel Blockers · 1Angiotensin-Ii Antagonists, Combinations · 1Quinolone Antibacterials · 1Cardiac Care · 1Drugs For Urinary Frequency And Incontinence · 1

Conditions treated

Angina · 1Bladder & Prostate Disorder · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official3 products · Rs 325.11 – Rs 617.69
DVAGO1 products · Rs 3,087.5 – Rs 3,087.5
Servaid2 products · Rs 197 – Rs 2,210
Median across source: Rs 1,203.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SEARLE PAKISTAN (PVT.) LTD. holds 237 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 156 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride
BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate

Get the full profile for A.J.

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.